fda restrictions on bpc-157 compounding advisory committee votes to add popular peptide to drug list A step towards expanded patient

A step towards expanded patient access. This will allow patients to have conversations about these compounds in the clinical setting instead of resorting to a gray market without practitioner oversight or monitoring! Remember the advisory committee is composed of handpicked members some of which have ties to compounding and peptides the backgrounds of the members and how they voted is informative. #bpc157 #peptides #fda # Exciting news for peptides coming out of today's committee hearing! The FDA Pharmacy Compounding Advisory Committee voted 8 6 to recommend adding BPC 157 to the 503A Bulks List for use in compounding for Understanding the Legal Risks of BPC 157 and Other Unapproved Peptides Holt Law FDA Panel Narrowly Backs Lifting Restrictions on Peptides Backed by RFK Jr. MedPage Today

SKU: 83226740776 · From metron-ms.com